Healthy Skepticism Library
Items published during the years 1980 to 1989
There are 1082 items in the Healthy Skepticism Library that were published during the years 1980 to 1989.
Page 9 of 11 pages ‹ First < 7 8 9 10 11 >
HSL3205
Massie BM, Rothenberg D.
Impact of pharmaceutical industry funding of clinical research: results of a survey of antianginal trials
Circulation 1984; 70:390
HSL3206
Morgan PP.
Pharmaceutical advertising in medical journals
Canadian Medical Association Journal 1984; 130:1412
HSL3207
Morris LA, Millstein LG.
Drug advertising to consumers: effects of formats for magazine and television advertisements
Food Drug Cosmetic Law Journal 1984; 39:497-503
HSL3208
Novitch M.
Direct-to-consumer advertising of prescription drugs
Food Drug Cosmetic Law Journal 1984; 39:306-311
HSL3209
Parboosingh J, Lockyer J, McDougall G, Chugh U.
How physicians make changes in their clinical practice: a study of physicians’ perception of factors that facilitate this process
Annals of the Royal College of Physicians and Surgeons of Canada 1984; 17:429-435
HSL3210
Peay MY, Peay ER.
Differences among practitioners in patterns of preference for information sources in the adoption of new drugs.
Soc Sci Med 1984; 18:(12):1019-25
HSL3211
Philbrook FA.
‘Misleading’ drug ad
Canadian Family Physician 1984; 30:272, 274
HSL3214
Rice DI.
The CFPC’s executive director replies
Canadian Family Physician 1984; 30:1454-1455
HSL3215
Rosner F.
Is academia going into business?
Cancer Invest 1984; 2:(6):493-5
HSL3216
Schapiro R.
Rx: consumer ads. Promoting prescription drugs to the consumer
New Physician 1984; 33:(4):8-11
HSL3217
Timmers R.
Legibility of advertisements
Lancet 1984; 2:1396
HSL3219
Turner J.
World health assembly
Lancet 1984; 1:1172-1173
HSL3220
Transnational corporations in the pharmaceutical industry of developing countries
1984;
HSL3221
Walden RJ.
Doctors and the drug makers
Lancet 1984; 2:405
HSL3223
Wright T.
Legibility of advertisements
Lancet 1984; 2:1396
HSL3224
Yarrow M.
Doctors and the drug makers
Lancet 1984; 2:405
HSL8396
Wolcott DL, Fawzy FI, Coombs RH.
Reinforcing networks: medical, pharmaceutical, mass media and paraphernalia establishments
Journal of Drug Issues 1984; 14:(2):223-231
HSL8398
Legislation Part 10: Control of smoking, alcoholism, and drug abuse: Drug abuse (narcotics, psychotropic drugs, and other dependence producing drugs)
International Digest of Health Legislation 1984; 35:(2):351-354
HSL8401
Vidt DG.
Comparative clinical trials--a clinical perspective.
Drug Inf J 1984; 18:(2):185-8
HSL8832
Hailey A.
Strong Medicine: A Novel
Pan: London 1984
http://www.amazon.com/Strong-Medicine-Novel-Arthur-Hailey/dp/0385504098/ref=si3_rdr_bb_product/102-3968322-5585731
HSL9038
Adams S.
Adams vs Roche.
London: Jonathan Cape 1984
http://www.amazon.com/Roche-Versus-Adams-Stanley/dp/022402180X/ref=sr_1_1/102-1249992-1219339?ie=UTF8&s=books&qid=1174977505&sr=8-1
HSL9076
Medawar C.
Drugs and World Health
London: Social Audit 1984
http://www.socialaudit.org.uk/122order.htm#1.22%20How%20to%20order
HSL16710
Bargmann E, Wolfe S
Letter to the Editor concerning Benzodiazepines
NEJM 1984; 310:465
HSL16711
Bargmann E, Wolfe S
Letter to the Editor concerning Long Term Diazepam Therapy
JAMA 1984; 251:1555
HSL3173
Ball JG, Snell ES.
Payments to doctors and the responsibilities of ethics committees
British Medical Journal 1983 Dec 17; 287:1884
HSL8446
Government says no to substitution-and cuts industry's profits
Pharmaceutical Journal 1983 Dec 17; 231:726-727
HSL19895
Round the World: Malaysia: Call For Reform of Drug Policies
The Lancet 1983 Dec 17; 1412
HSL8447
White JP.
Prescriptions: new products set pace
Drug Topics 1983 Dec 12; 127:53-54, 56
HSL3171
Howie JG.
Doctors and the pharmaceutical industry [1st of 2 letters]
Journal of the Royal College of General Practitioners 1983 Dec; 33:825
HSL3172
Taylor GB.
Doctors and the pharmaceutical industry [2nd of 2 letters]
Journal of the Royal College of General Practitioners 1983 Dec; 33:825
HSL8406
Brodrick A, Preece G, Bird HA, Wright V.
Factors that may influence the prescribing habits of rheumatologists.
J Clin Hosp Pharm 1983 Dec; 8:(4):333-8
HSL8438
Rosen AM.
Bringing reason to the drug advertising debate
Pharmaceutical Technology 1983 Dec; 7:20-21
HSL16709
Wolfe S
Don't Ignore This Danger Signal
USA Today 1983 Nov 23
HSL3169
Re: the promotion of products containing amidopyrine
1983 Nov;
HSL3170
Tiranti D.
Hunger and the wonder drug
New Internationalist 1983 Nov
HSL8440
Rosen AM.
In favor of consumer Rx ads: let's argue examples, not principles
Pharmaceutical-Executive 1983 Nov; 3:26, 92
HSL16708
Wolfe S
Non?Prescription Drugs: How Safe?
The LA Times 1983 Oct 24
HSL5229
Rovner S.
Health Talk: Mixed Bag
The Washington Post 1983 Oct 21
HSL3135
Avorn J, Soumerai SB.
A new approach to reducing suboptimal drug use.
JAMA 1983 Oct 7; 250:(13):1752-3
HSL3136
Barker C.
The Mozambique pharmaceutical policy.
Lancet 1983 Oct 1; 2:(8353):780-2
HSL3168
Phillips DJ, Smith JE.
Hospital-based training for pharmaceutical manufacturers' representatives.
Am J Hosp Pharm 1983 Oct; 40:(10):1661-3
HSL8407
Miller RW.
Would Rx ads make people learn or yearn?
FDA Consum 1983 Oct; 17:(8):24-7
HSL8448
Cardinale V, Glaser M.
Selling of the pharmacy
Drug Topics 1983 Sep 5; 127:38-42, 44, 49
HSL8402
Van der Geest S
Medicines in the third world; sale without restriction and misuse
Pharmaceutisch Weekblad 1983 Sep 2; 1118:723-732
HSL3166
Millstein LG.
The regulation of prescription drug advertising.
Am Pharm 1983 Sep; NS23:(9):54-7
HSL3167
Schofield TP.
The relationship between the college and the pharmaceutical industry.
J R Coll Gen Pract 1983 Sep; 33:(254):601-3
HSL8442
These low pressure ladies form a potent sales force
American Druggist 1983 Sep; 188:140, 142
HSL8443
Lamy PP.
Drug abuse by older adults--who is responsible?
Drug Intell Clin Pharm 1983 Sep; 17:(9):657-9
HSL8453
Nonprescription drug sales up in 82
American Pharmacy 1983 Sep; 13
HSL8455
Curtiss FR.
Pharmacy management strategies for responding to hospital reimbursement changes
American Journal of Hospital Pharmacy 1983 Sep; 40:1489-1492
HSL8436
Schwartz H.
Rx TV ads: fad or fixture?
Pharmaceutical Executive 1983 Aug; 3:12, 14
HSL8437
Kaplan A, Becker R.
Constitutional issues in the Boots aftershock
Pharmaceutical Executive 1983 Aug; 3:78, 80
HSL8452
Final judgment on advertising - US District Court
American Pharmacy 1983 Aug; 54-56
HSL3133
Pharmaceutical policies for the Third World--whose responsibility.
Lancet 1983 Jul 16; 2:(8342):144
HSL3152
Musher DM.
Antibiotics: the medium is the message.
Rev Infect Dis 1983 Jul-Aug; 5:(4):809-12
HSL3165
Willcox GS, Mahoney CD, Jeffrey LP.
Monitoring the hospital activities of medical service representatives.
Am J Hosp Pharm 1983 Jun; 40:(6):989-91
HSL3131
Drug companies and rheumatologists.
Br J Rheumatol. 1983 May 22; 2:65-6
HSL8450
Mercill AW.
Searching for O-T-C opportunities
Pharmaceutical Executive 1983 May; 3:26-29
HSL8451
Kushner D.
Make pharmacists your partners in O-T-C promotion
Pharmaceutical Executive 1983 May; 3:30-31
HSL3164
Kolata G.
Prescription drug ads put FDA on the spot.
Science 1983 Apr 22; 220:(4595):387-8
HSL8449
Millstein LG.
FDA policy on comparative prescription drug advertising
Drug Information Journal 1983 Apr 7; 17:63-66
HSL3139
Brooks PM, Birkett D.
Release of new drugs. The lessons of benoxaprofen
Med J Aust. 1983 Mar 19; 1:(6):251-2
HSL8403
Plumridge RJ.
Review of factors influencing drug prescribing. Part 1
Australian Journal of Hospital Pharmacy 1983 Mar; 13:16-19
HSL3162
Getting good value from drug reps.
Drug Ther Bull. 1983 Feb 25; 21:(4):13-5
HSL3130
Doctors and the drug industry.
Br Med J (Clin Res Ed). 1983 Feb 19; 286:(6365):579-80
HSL8456
van der Geest S
Non-information for patients: selling drugs in developing countries
Pharm Int 1983 Feb; 4:42-44
HSL8462
Some Rx drug makers are using discount coupons
American Druggist 1983 Feb; 187: 53
HSL3132
'Opren scandal'
Lancet 1983 Jan 29;1(8318):219-20 1983 Jan 29; 1:(8318):219-20
HSL3161
Mangold T.
Relationships between doctors and salesment are lurching out of control
The Listener (London) 1983 Jan 202-4
HSL3147
Harvey K.
Promotion of newer antimicrobial agents.
Med J Aust 1983 Jan 8; 1:(1):27-8
HSL3154
Osifo NG.
Overpromotion of drugs in international product package inserts.
Trop Doct 1983 Jan; 13:(1):5-8
HSL3160
Massengill R Jr, Verghese A, Robert T.
Course for drug representatives.
J Med Educ 1983 Jan; 58:(1):86
HSL3134
Alloza JL, Lasagna L.
A comparison of drug product information in four national compendia
Clinical Pharmacology and Therapeutics 1983; 33:269-277
HSL3137
Beardshaw V.
Prescription for change: Health Action International’s guide to rational health projects
1983;
HSL3138
Breslow RA.
Junk mail
New England Journal of Medicine 1983; 308:1168
HSL3140
Connors JM.
More on junk mail
New England Journal of Medicine 1983; 309:673-674
HSL3141
De Maar EW, Kshirsagar NA, Darmansjah I.
An Asian perspective on drug and related health care information.
Drug Inf J 1983; 17:(4):263-9
HSL3142
Deitch R.
The government and the activities of the pharmaceutical industry
Lancet 1983; 2:1432-1433
HSL3143
French TA.
Commercial approach of pharmaceutical industry
BMJ 1983; 287:1632
HSL3144
Generali JA, Hogan L.
A comparison of pharmaceutical manufacturers as a source of drug information to a telephone inquiry: generic vs brand.
Drug Inf J 1983; 17:(3):195-204
HSL3145
Goldberg D.
Tales from the Vienna Woods
Lancet 1983; 2:393
HSL3146
Gray R, Smith M.
Is criticism of tranquilizer advertising justified?
Medical Marketing & Media 1983; 18:(7):50, 52, 54-55, 58-59
HSL3148
Kass EH.
Seduction in a grand hotel
Reviews of Infectious Diseases 1983; 5:973-974
HSL3149
Klein T.
Detailing and other forms of promotion
1983; 400-417
HSL3150
Lumbard J.
Foremost problem? Medical service representatives
Hospital Pharmacy 1983; 18:134
HSL3151
McAuley RG, Little F.
Junk mail
Canadian Medical Association Journal 1983; 129:1174, 1176
HSL3153
O’Connor JF.
Research, critical thinking and the pharmaceutical industry
Nova Scotia Medical Bulletin 1983; 62:66
HSL3155
Phillips I.
Supplements
Journal of Antimicrobial Chemotherapy 1983; 12:199-200
HSL3156
Quraeshi ZA, Luqmani M, Malhotra N.
Brands or generics: the dilemma of pharmaceutical marketing in a developing country.
J Health Care Mark 1983 Fal; 3:(4):27-37
HSL3157
Smith MC.
An analysis of the impact of print advertising on prescribing
1983; 259-278
HSL3158
Waldman RH.
Cost of antibiotics
JAMA 1983; 250:1693-1694
HSL3159
Wright L.
Pharmaceutical advertising
New Zealand Medical Journal 1983; 96:407
HSL3163
Truth in drug advertising
Dispatch 1983; (25):1-5
HSL3174
Gundry DRT.
The big spenders
British Medical Journal 1983; 287:1884
HSL8435
Wahli HR.
Information for the patient-information for the doctor
Swiss Pharma 1983; 5:(11):7-14
HSL8439
Koskikallio I.
Special characteristics of drugs and drug markets
Journal of Drug Issues 1983; 13:(1):167-177
HSL8445
Marcus D.
FDA approval of comparative claims for prescription drugs--the Moxam case.
Drug Inf J 1983; 17:(3):171-5
HSL16707
Wolfe S
Review of Prescriptions for Death: The Drugging of the Third World
Journal of Public Health Policy 1983; 4:(1):115‑116
HSL16712
Bargmann E, Greenberg A, Kowey P, Wolfe S
Letter to the Editor on Conflicting Views Regarding the Frequency of Unnecessary Pacemaker Implants
Am. J. Cardiol 1983; 51:1042‑1043
HSL3097
The influence of drug advertisements.
Lancet. 1982 Dec 4; 2:(8310):1257-8
Page 9 of 11 pages ‹ First < 7 8 9 10 11 >
